Heterogeneity in CIN3 diagnosis

The Lancet Oncology

Volumn 9, Issue 5, 2008, Pages 404-406

  Schiffman, Mark ^a   Rodríguez, Ana Cecilia ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SCREENING; COLPOSCOPY; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; LETTER; OUTCOMES RESEARCH; PRECANCER; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS CARCINOGENESIS; WART VIRUS;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DISEASE PROGRESSION; FEMALE; HUMANS; HYSTERECTOMY; INCIDENCE; KAPLAN-MEIERS ESTIMATE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEW ZEALAND; PROPORTIONAL HAZARDS MODELS; REFUSAL TO TREAT; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VAGINAL SMEARS;

EID: 42949136605     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70110-4     Document Type: Letter

References (10)

1. McCredie M., Sharples K., Paul C., et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9 (2008) 425-434
2. McIndoe W., McLean M., Jones R., and Mullins P. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 64 (1984) 451-458
3. Schiffman M., Castle P., Jeronimo J., Rodriguez A., and Wacholder S. Human papillomavirus and cervical cancer. Lancet 370 (2007) 890-907
4. Sherman M., Wang S., Tarone R., Rich L., and Schiffman M. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev 12 (2003) 372-379
5. Schiffman M., Herrero R., Desalle R., et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337 (2005) 76-84
6. Winer R., Kiviat N., Hughes J., et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191 (2005) 731-738
7. Schlecht N., Kulaga S., Robitaille J., et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286 (2001) 3106-3114
8. Koutsky L., and Harper D. Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine 24 suppl 3 (2006) S114-S121
9. Wright Jr. T., Massad L., Dunton C., et al. American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 197 (2007) 340-345
10. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., and Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367 (2006) 489-498